Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
AKT2 208 ARQ-092 CHEMBL3545422 inhibitor, allosteric modulator GuideToPharmacologyInteractions, ChemblInteractions
AKT2 208 IPATASERTIB CHEMBL2177390 inhibitor TdgClinicalTrial, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, MyCancerGenomeClinicalTrial
AKT2 208 AFURESERTIB CHEMBL2219422 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
AKT2 208 GSK-690693 CHEMBL494089 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
AKT2 208 AZD-4547 CHEMBL3184679 inhibitor MyCancerGenomeClinicalTrial
AKT2 208 EVEROLIMUS CHEMBL1908360 inhibitor MyCancerGenomeClinicalTrial
AKT2 208 A-443654 CHEMBL379300 inhibitor GuideToPharmacologyInteractions, DrugBank 10592235
AKT2 208 LY-2780301 CHEMBL3545134 inhibitor ChemblInteractions
AKT2 208 MK-2201 CHEMBL3545000 inhibitor ChemblInteractions
AKT2 208 TRICIRIBINE PHOSPHATE CHEMBL462018 inhibitor ChemblInteractions
AKT2 208 PERIFOSINE CHEMBL372764 TdgClinicalTrial
AKT2 208 BAY-1125976 CHEMBL3545049 inhibitor ChemblInteractions
AKT2 208 CHEMBL428462 CHEMBL428462 DrugBank 10592235
AKT2 208 XL-418 CHEMBL3544935 inhibitor TdgClinicalTrial, ChemblInteractions
AKT2 208 AZD-5363 CHEMBL2178577 inhibitor ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions
AKT2 208 MK-2206 CHEMBL1079175 inhibitor, allosteric modulator ClearityFoundationClinicalTrial, CGI, ChemblInteractions, TdgClinicalTrial, MyCancerGenomeClinicalTrial, GuideToPharmacologyInteractions
AKT2 208 CHEMBL227381 CHEMBL227381 DrugBank 10592235
AKT2 208 TRICIRIBINE CHEMBL331237 TdgClinicalTrial, ClearityFoundationClinicalTrial
AKT2 208 AFURESERTIB HYDROCHLORIDE CHEMBL2219423 ClearityFoundationClinicalTrial
AKT2 208 UPROSERTIB CHEMBL3137336 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
AKT2 208 OMIPALISIB CHEMBL1236962 inhibitor MyCancerGenomeClinicalTrial
AKT2 208 TRASTUZUMAB CHEMBL1201585 CIViC 22842582

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
AKT2 rs34716810 AA carboplatin efficacy no No association was seen between this SNP and duration of progression free survival. Odds ratio below is for disease progression. Genotype AA is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG. 22901187 1183699188
AKT2 rs62107593 CC carboplatin efficacy no No association was seen between this SNP and duration of progression free survival. Odds ratio below is for disease progression. Genotype CC is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CG + GG. 22901187 1183699207